<!DOCTYPE html>
<html>

<head>
  <meta charset="utf-8">
  <!-- Meta tags for social media banners, these should be filled in appropriatly as they are your "business card" -->
  <!-- Replace the content tag with appropriate information -->
  <meta name="description" content="DESCRIPTION META TAG">
  <meta property="og:title" content="SOCIAL MEDIA TITLE TAG" />
  <meta property="og:description" content="SOCIAL MEDIA DESCRIPTION TAG TAG" />
  <meta property="og:url" content="URL OF THE WEBSITE" />
  <!-- Path to banner image, should be in the path listed below. Optimal dimenssions are 1200X630-->
  <meta property="og:image" content="static/image/your_banner_image.png" />
  <meta property="og:image:width" content="1200" />
  <meta property="og:image:height" content="630" />


  <meta name="twitter:title" content="MedBN: Robust Test-Time Adaptation against Malicious Test Samples">
  <meta name="twitter:description" content="The project page of MedBN (CVPR 2024)">
  <!-- Path to banner image, should be in the path listed below. Optimal dimenssions are 1200X600-->
  <meta name="twitter:image" content="static/images/your_twitter_banner_image.png">
  <meta name="twitter:card" content="summary_large_image">
  <!-- Keywords for your paper to be indexed by-->
  <meta name="keywords" content="KEYWORDS SHOULD BE PLACED HERE">
  <meta name="viewport" content="width=device-width, initial-scale=1">


  <title>MedBN: Robust Test-Time Adaptation against Malicious Test Samples</title>
  <link href="https://fonts.googleapis.com/css?family=Google+Sans|Noto+Sans|Castoro" rel="stylesheet">
  <link rel="icon" type="image/x-icon" href="static/images/favicon.ico">

  <link rel="stylesheet" href="static/css/bulma.min.css">
  <link rel="stylesheet" href="static/css/bulma-carousel.min.css">
  <link rel="stylesheet" href="static/css/bulma-slider.min.css">
  <link rel="stylesheet" href="static/css/fontawesome.all.min.css">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css">
  <link rel="stylesheet" href="static/css/index.css">

  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.5.1/jquery.min.js"></script>
  <script src="https://documentcloud.adobe.com/view-sdk/main.js"></script>
  <script defer src="static/js/fontawesome.all.min.js"></script>
  <script src="static/js/bulma-carousel.min.js"></script>
  <script src="static/js/bulma-slider.min.js"></script>
  <script src="static/js/index.js"></script>

</head>
</head>

<body>

  <section class="hero">
    <div class="hero-body">
      <div class="container is-max-desktop">
        <div class="columns is-centered">
          <div class="column has-text-centered">
            <h1 class="title is-1 publication-title">MedBN: Robust Test-Time Adaptation against Malicious Test Samples
            </h1>
            <p class="title is-4 publication-title">CVPR 2024</p>
            <div class="is-size-5 publication-authors">
              <!-- Paper authors -->
              <span class="author-block">Hyejin Park<sup>*</sup>,</span>
              <span class="author-block">Jeongyeon Hwang<sup>*</sup>,</span>
              <span class="author-block">Sunung Mun</sup>,</span>
              <span class="author-block">Sangdon Park</sup>,</span>
              <span class="author-block">Jungseul Ok</span>
            </div>

            <div class="is-size-5 publication-authors">
              <span class="author-block">Pohang University of Science and Technology (POSTECH)</span>
              <span class="eql-cntrb"><small><br><sup>*</sup> Equal Contribuion</small></span>
            </div>

            <div class="column has-text-centered">
              <div class="publication-links">
                <!-- Arxiv PDF link -->
                <span class="link-block">
                  <a href="https://arxiv.org/pdf/2403.19326" target="_blank"
                    class="external-link button is-normal is-rounded is-dark">
                    <span class="icon">
                      <i class="fas fa-file-pdf"></i>
                    </span>
                    <span>Paper</span>
                  </a>
                </span>

                <!-- Supplementary PDF link -->
                <span class="link-block">
                  <a href="static/pdfs/cvpr24_medbn_poster_final.pdf" target="_blank"
                    class="external-link button is-normal is-rounded is-dark">
                    <span class="icon">
                      <i class="fas fa-file-pdf"></i>
                    </span>
                    <span>Poster</span>
                  </a>
                </span>

                <!-- Github link -->
                <span class="link-block">
                  <a href="https://github.com/ml-postech/MedBN-robust-test-time-adaptation" target="_blank"
                    class="external-link button is-normal is-rounded is-dark">
                    <span class="icon">
                      <i class="fab fa-github"></i>
                    </span>
                    <span>Code</span>
                  </a>
                </span>

                <!-- ArXiv abstract Link -->
                <span class="link-block">
                  <a href="https://arxiv.org/abs/2403.19326" target="_blank"
                    class="external-link button is-normal is-rounded is-dark">
                    <span class="icon">
                      <i class="ai ai-arxiv"></i>
                    </span>
                    <span>arXiv</span>

                    <!-- Video Link. -->
                    <span class="link-block">
                      <a href="https://www.youtube.com/watch?v=MZZ2iW9jeuM"
                        class="external-link button is-normal is-rounded is-dark">
                        <span class="icon">
                          <i class="fab fa-youtube"></i>
                        </span>
                        <span>Video</span>
                      </a>
                    </span>
                  </a>
                </span>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- vulnerability vs. robustness -->
  <section class="hero teaser" style="margin-top: -2em;">
    <div class=" container is-max-desktop">
      <div class="hero-body">
        <div class="hero-body-center"><img src="./static/images/f1-mean-vs-median.png"
            style="width: 30em; margin-bottom: -0.5em"></div>
        <h2 class="title is-6 has-text-centered"> A potential security flaw in test-time adaptation process [1]:
          vulnerablity of mean in batch normalization layers
        </h2>
        <h5 class="subtitle is-6">
          While Test-Time Adaptation (TTA) methods excel in adapting to test data variations, such adaptability exposes
          a model to vulnerability against malicious examples, particularly when a small proportion of the test batch is
          maliciously
          manipulated.
        </h5>
      </div>
    </div>
  </section>
  <!-- End -->

  <!-- overview of medbn -->
  <section class="hero teaser" style="margin-bottom: 2em;">
    <div class="container is-max-desktop">
      <div class="hero-body">
        <!-- <h2 class="title is-3 has-text-centered">Median Batch Normalization (MedBN)</h2> -->
        <div class="hero-body-center"><img src="./static/images/f2-medbn-overview.png"
            style="width: 27em; margin-bottom: -0.5em"></div>
        <h2 class=" title is-6 has-text-centered"> The process of batch normalizing
          tranformation (Batch Normalization
          vs. MedBN (Ours))
        </h2>
        <h5 class=" subtitle is-6">
          ‚úÖ In response to the threat of malicious samples,
          we introduce <b>a simple and effective robust batch normalzation method, Median Batch
            Normalization (MedBN),</b> which
          uses the median instead of mean to estimate the batch statistics.
          Our method is algorithm-agnostic, thus allowing <u>seamless integration</u>
          with existing TTA frameworks.
          <br>
          <br>
          [1] Wu, Tong, et al. "Uncovering adversarial risks of test-time adaptation." <i>International Conference on Machine Learning</i>. 2023.
        </h5>
      </div>
    </div>
  </section>
  <!-- End overview of medbn -->


  <!-- paper abstract -->
  <section class="section hero is-light">
    <section class="hero teaser">
      <div class="container is-max-desktop">
        <div class="hero-body">
          <div class="columns is-centered has-text-centered">
            <div class="column is-four-fifths" style="margin-bottom: -1em">
              <h2 class=" title is-3">Abstract</h2>
              <div class="content has-text-justified">
                <p>
                  Test-time adaptation (TTA) has emerged as a promising solution to address performance decay due to
                  unforeseen distribution shifts between training and test data. While recent TTA methods excel in
                  adapting to test data variations, such adaptability exposes a model to vulnerability against malicious
                  examples. Indeed, previous studies have uncovered security vulnerabilities within TTA even when a
                  small proportion of the test batch is maliciously manipulated. In response to the emerging threat, we
                  propose median batch normalization (MedBN), leveraging the robustness of the median for statistics
                  estimation within the batch normalization layer during test-time inference. Our method is
                  algorithm-agnostic, thus allowing seamless integration with existing TTA frameworks. Our experimental
                  results on benchmark datasets, including CIFAR10-C, CIFAR100-C, and ImageNet-C, consistently
                  demonstrate that MedBN outperforms existing approaches in maintaining robust performance across
                  different attack scenarios, encompassing both instant and cumulative attacks. Through extensive
                  experiments, we show that our approach sustains the performance even in the absence of attacks,
                  achieving a practical balance between robustness and performance.
                  <!-- Our code is available at https://github.com/mlpostech/MedBN-robust-test-time-adaptation. -->
                </p>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>
  </section>
  <!-- End paper abstract -->

  <!-- main results-->
  <section class="hero teaser">
    <div class="container is-max-desktop">
      <div class="hero-body" style="margin-top: 2em;">
        <h2 class="title is-3 has-text-centered">Main Results</h2>
        <h5 style="margin-bottom: 1em;">We consider seven TTA methods which update batch statistics or the affine
          parameters of batch normalization layers and evaluate our approach using three major benchmarks for TTA:
          CIFAR10-C, CIFAR100-C, and ImageNet-C. For further details, please refer to our paper.</h5>
        <!-- Targeted Attack-->
        <h2 class="title is-4 has-text-centered">üèπ Targeted Attack Scenarios (Table 1 in paper)</h2>
        <div class="hero-body-center">
          <img src="./static/images/Table1.png" style="width: 50em; margin-bottom: -1em">
        </div>

        <h5 class="subtitle is-6">
          <b>‚Ä¢ Scenrario description:</b> The objective of a targeted attack is to manipulate the model into predicting a
          targeted label
          on a targeted sample, using malicious samples in a batch.
          <br><b>‚Ä¢ Evalutation metric: </b> Attack Success Rate (ASR; %). ‚¨áÔ∏è is better.
          <br><b>‚Ä¢ Results: </b> The ASRs of <u>all TTA methods using MedBN</u> are consistently less than 20% for
          CIFAR10-C, 10% for CIFAR100-C, and 1% for ImageNet-C.
          <br><br>
        </h5>
        <!-- Indiscriminate Attack-->
        <h2 class="title is-4 has-text-centered">üìâ Indiscriminate Attack Scenarios (Table 2 in paper)</h2>
        <div class="hero-body-center">
          <img src="./static/images/Table2.png" style="width: 50em; margin-bottom: -1em">
        </div>
        <h5 class="subtitle is-6">
          <b>‚Ä¢ Scenrario description:</b> The objective of an indiscriminate attack is to degrade the performance of
          benign
          samples.
          <br><b>‚Ä¢ Evalutation metric: </b> Error Rate (ER; %) on benign samples. ‚¨áÔ∏è is better.
          <br><b>‚Ä¢ Results: </b> <u>All TTA methods using MedBN</u> shows reduced ERs as
          high as approximately 9% in CIFAR10-C, 11% in CIFAR100-C, and 12% in ImageNet-C.
        </h5>
      </div>
    </div>
    </div>
    </div>
  </section>medbn-overview

  <!-- For making Table -->
  <table class="tg" style="margin-left:auto;margin-right:auto; text-align: center;">
    <thead>
      <tr>
        <th class="tg-6rtx"><span style="font-weight:bold">Dataset</span></th>
        <th class="tg-6rtx"><span style="font-weight:bold"><i>B / m</span></th>
        <th class="tg-6rtx"><span style="font-weight:bold">Normalization</span></th>
        <th class="tg-6rtx"><span style="font-weight:bold" colspan="7">Method</span></th>
        <th class="tg-6rtx"><span style="font-weight:bold"><i>m</i>=0</span></th>

      </tr>
    </thead>
    <tbody>
      <tr>
        <td colspan="5" class="tg-io7e" style="background-color: #f0f0f0;">ResNet50 backbone</td>
      </tr>
      <tr>
        <td class="tg-6aag">LDAM (NeurIPS'2019)</td>
        <td class="tg-io7e">49.8</td>
        <td class="tg-io7e">60.4</td>
        <td class="tg-io7e">46.9</td>
        <td class="tg-io7e">30.7</td>
      </tr>
      <tr>
        <td class="tg-hcx2">RIDE (3 exp.) (ICLR'2021)</td>
        <td class="tg-io7e">54.9</td>
        <td class="tg-io7e">66.2</td>
        <td class="tg-io7e">51.7</td>
        <td class="tg-io7e">34.9</td>
      </tr>
      <tr>
        <td class="tg-hcx2">BCL (NeurIPS'2020)</td>
        <td class="tg-io7e">57.1</td>
        <td class="tg-io7e">67.9</td>
        <td class="tg-io7e">54.2</td>
        <td class="tg-io7e">36.6</td>
      </tr>
      <tr>
        <td class="tg-6aag"><sup>1</sup>LDAM+DRW+SAM (NeurIPS'2022)</td>
        <td class="tg-io7e">53.1</td>
        <td class="tg-io7e">62.0</td>
        <td class="tg-io7e">52.1</td>
        <td class="tg-io7e">32.8</td>
      </tr>
      <tr>
        <td class="tg-6aag"><sup>2</sup>PaCo+SAM (ICCV'2021, NeurIPS'2022)</td>
        <td class="tg-io7e">57.5</td>
        <td class="tg-io7e">62.1</td>
        <td class="tg-io7e">58.8</td>
        <td class="tg-io7e">39.3</td>
      </tr>
      <tr>
        <td colspan="5" class="tg-io7e" style="background-color: #f0f0f0;">ViT backbone</td>
      </tr>
      <tr>
        <td class="tg-6aag">ViT (ICML'2021)</td>
        <td class="tg-io7e">37.5</td>
        <td class="tg-io7e">56.9</td>
        <td class="tg-io7e">30.4</td>
        <td class="tg-io7e">10.3</td>
      </tr>
      <tr>
        <td class="tg-6aag">DeiT-III (ECCV'2022)</td>
        <td class="tg-io7e">48.4</td>
        <td class="tg-io7e">70.4</td>
        <td class="tg-io7e">40.9</td>
        <td class="tg-io7e">12.8</td>
      </tr>
      <tr>
        <td class="tg-6aag"><sup>1</sup><span style="font-weight:bold">DeiT-LT (ours)</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">55.6</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">65.2</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">54.0</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">37.1</span></td>
      </tr>
      <tr>
        <td class="tg-6aag"><sup>2</sup><span style="font-weight:bold">DeiT-LT (ours)</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">59.1</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">66.6</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">58.3</span></td>
        <td class="tg-io7e"><span style="font-weight:bold">40.0</span></td>
      </tr>
    </tbody>
  </table>
  <!-- End main results -->

  <!-- Image carousel -->
  <!-- <section class="hero is-small">
    <div class="hero-body">
      <div class="container">
        <div id="results-carousel" class="carousel results-carousel">
          <div class="item"> -->
  <!-- Your image here -->
  <!-- <img src="static/images/carousel1.jpg" alt="MY ALT TEXT" />
              <h2 class="subtitle has-text-centered">
                First image description.
              </h2>
            </div>
            <div class="item"> -->
  <!-- Your image here -->
  <!-- <img src="static/images/carousel2.jpg" alt="MY ALT TEXT" />
              <h2 class="subtitle has-text-centered">
                Second image description.
              </h2>
            </div>
            <div class="item"> -->
  <!-- Your image here -->
  <!-- <img src="static/images/carousel3.jpg" alt="MY ALT TEXT" />
              <h2 class="subtitle has-text-centered">
                Third image description.
              </h2>
            </div>
            <div class="item"> -->
  <!-- Your image here -->
  <!-- <img src="static/images/carousel4.jpg" alt="MY ALT TEXT" />
            <h2 class="subtitle has-text-centered">
              Fourth image description.
            </h2>
          </div>
        </div>
      </div>
    </div>
  </section> -->
  <!-- End image carousel -->


  <!-- Youtube video -->
  <!-- <section class="hero is-small is-light">
    <div class="hero-body">
      <div class="container"> -->
  <!-- Paper video. -->
  <!-- <h2 class="title is-3">Video Presentation</h2>
        <div class="columns is-centered has-text-centered">
          <div class="column is-four-fifths">

            <div class="publication-video"> -->
  <!-- Youtube embed code here -->
  <!-- <iframe src="https://www.youtube.com/embed/JkaxUblCGz0" frameborder="0" allow="autoplay; encrypted-media"
                allowfullscreen></iframe>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section> -->
  <!-- End youtube video -->



  <!-- Paper poster -->
  <!-- <section class="hero is-small is-light">
    <div class="hero-body">
      <div class="container">
        <h2 class="title">Poster</h2>

        <iframe src="static/pdfs/sample.pdf" width="100%" height="550">
        </iframe>

      </div>
    </div>
  </section> -->
  <!--End paper poster -->


  <!-- Teaser video-->
  <!-- <section class="hero teaser">
  <div class="container is-max-desktop">
    <div class="hero-body">
      <video poster="" id="tree" autoplay controls muted loop height="100%"> -->
  <!-- Your video here -->
  <!-- <source src="static/videos/banner_video.mp4" -->
  <!-- type="video/mp4"> -->
  <!-- </video> -->
  <!-- <h2 class="subtitle has-text-centered"> -->
  <!-- Aliquam vitae elit ullamcorper tellus egestas pellentesque. Ut lacus tellus, maximus vel lectus at, placerat pretium mi. Maecenas dignissim tincidunt vestibulum. Sed consequat hendrerit nisl ut maximus.  -->
  <!-- </h2> -->
  <!-- </div> -->
  <!-- </div> -->
  <!-- </section> -->
  <!-- End teaser video -->


  <!--BibTex citation -->
  <section class="section" id="BibTeX">
    <div class="container is-max-desktop content">
      <h2 class="title">BibTeX</h2>
      <pre><code>@article{park2024medbn,
        title={MedBN: Robust Test-Time Adaptation against Malicious Test Samples},
        author={Park, Hyejin and Hwang, Jeongyeon and Mun, Sunung and Park, Sangdon and Ok, Jungseul},
        journal={arXiv preprint arXiv:2403.19326},
        year={2024}
      }</code></pre>
    </div>
  </section>
  <!--End BibTex citation -->


  <footer class="footer">
    <div class="container">
      <div class="columns is-centered">
        <div class="column is-8">
          <div class="content">

            <p>
              This page was built using the <a href="https://github.com/eliahuhorwitz/Academic-project-page-template"
                target="_blank">Academic Project Page Template</a> which was adopted from the¬†<a
                href="https://nerfies.github.io" target="_blank">Nerfies</a>¬†project page.
              You are free to borrow the of this website, we just ask that you link back to this page in the footer.
              This website is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-sa/4.0/"
                target="_blank">Creative
                Commons Attribution-ShareAlike 4.0 International License</a>.
            </p>

          </div>
        </div>
      </div>
    </div>
  </footer>

  <!-- Statcounter tracking code -->

  <!-- You can add a tracker to track page visits by creating an account at statcounter.com -->

  <!-- End of Statcounter Code -->

</body>

</html>
